Oxidative Medicine and Cellular Longevity / 2017 / Article / Fig 7

Research Article

circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis

Figure 7

Characteristics of circRNA_0046367/miR-34a/PPARα regulatory system in hepatic steatosis. (a) HE staining identifies patients with (steatosis group) or without hepatic steatosis (control group), respectively. (b) Expression level of circRNA_0046367 and degree of hepatic steatosis (b). (c), (d) mRNA levels of hepatic miR-34a (c) and PPARα (d), respectively, in groups of control and steatosis. (e), (f) Western blot for the hepatic expression of PPARα (e) with relative quantification against β-actin (f) in different groups. The presented results are expressed as means ± S.D. Control group versus steatosis group: .
(a)
(b)
(c)
(d)
(e)
(f)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.